Oncology & Cancer

The dilemma of screening for prostate cancer

Primary care providers are put in a difficult position when screening their male patients for prostate cancer—some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate ...

Oncology & Cancer

Popular prostate cancer therapy may be harmful

A widely used treatment for prostate cancer may cause more harm than good for some patients, according to Dr. Oliver Sartor, medical director of the Tulane Cancer Center.

Oncology & Cancer

Benefit of aggressive prostate CA Tx weakens as comorbidity rises

(HealthDay)—For men with early-stage prostate cancer, the cancer-specific survival benefit associated with aggressive prostate cancer treatment is reduced with increasing comorbidity, according to a study published online ...

page 5 from 9